Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-09 · accession 0001968202-24-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-12 | 2024-02-09 | REGN | Fenimore Christopher R. | CFO, SVP Fin | S - Sale | $953.31 | -4,919 | 17.4K | -22% | -$4.69M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | S | D | 1,342 | $953.47 | 16,072 | D | — | — | (F4) Represents volume-weighted average price of sales of 1,342 shares of Company stock on February 9, 2024 at prices ranging from $953.02 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price. |
| 2 | Common | Common Stock | 2024-02-09 | S | D | 600 | $955.00 | 14,372 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-09 | S | D | 1,100 | $954.57 | 14,972 | D | — | — | (F5) Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 9, 2024 at prices ranging from $954.00 to $954.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-02-09 | S | D | 344 | $950.49 | 18,947 | D | — | — | (F1) Represents volume-weighted average price of sales of 344 shares of Company stock on February 9, 2024 at prices ranging from $950.33 to $950.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-02-09 | S | D | 487 | $951.39 | 18,460 | D | — | — | (F2) Represents volume-weighted average price of sales of 487 shares of Company stock on February 9, 2024 at prices ranging from $951.03 to $951.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-02-09 | S | D | 1,046 | $952.62 | 17,414 | D | — | — | (F3) Represents volume-weighted average price of sales of 1,046 shares of Company stock on February 9, 2024 at prices ranging from $952.11 to $952.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price. |